Compare LESL & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LESL | LGVN |
|---|---|---|
| Founded | 1963 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Medicinal Chemicals and Botanical Products |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.4M | 11.9M |
| IPO Year | 2020 | 2021 |
| Metric | LESL | LGVN |
|---|---|---|
| Price | $1.00 | $0.93 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 6 | 1 |
| Target Price | $2.54 | ★ $3.00 |
| AVG Volume (30 Days) | 109.6K | ★ 8.9M |
| Earning Date | 05-07-2026 | 03-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 50.76 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,241,915,000.00 | $709,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.37 | $1,183.95 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.27 | $0.48 |
| 52 Week High | $6.92 | $1.83 |
| Indicator | LESL | LGVN |
|---|---|---|
| Relative Strength Index (RSI) | 43.75 | 58.29 |
| Support Level | $0.90 | $0.55 |
| Resistance Level | $1.23 | $1.44 |
| Average True Range (ATR) | 0.10 | 0.14 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 20.89 | 44.55 |
Leslies Inc is a direct-to-consumer pool and spa care brand offering a comprehensive assortment of products, including chemicals, equipment and parts, cleaning and maintenance equipment, and safety, recreational, and fitness-related products. The company serves residential pool, residential spa, professional pool, and commercial pool consumers and markets its products through over 1,000 company-operated locations in 39 states and e-commerce websites, operating only in the United States. It operates mainly in the pool and spa aftermarket industry and offers regularly purchased, non-discretionary maintenance items, along with installation and repair services for pool and spa equipment.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.